Different clinical aspects of debrancher deficiency myopathy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 3, 1999, Pages 364-368

  Kiechl, Stefan ^a   Kohlendorfer, Ursula ^a   Thaler, Claudia ^a   Skladal, Daniela ^a   Jaksch, Michaela ^b   Obermaier Kusser, Bert ^b   Willeit, Johann ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b Klinikum Schwabing   (Germany)

Author keywords

Debrancher deficiency; Glycogen storage disease; Glycogenosis; Myopathy

Indexed keywords

CREATINE KINASE;

ADULT; ARTICLE; AUSTRIA; BREATHING MUSCLE; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ELECTROMYOGRAPHY; ENZYME ACTIVITY; EXERCISE TOLERANCE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 3; HUMAN; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER DYSFUNCTION; MALE; MUSCLE BIOPSY; MYOPATHY; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 0032791337     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.3.364     Document Type: Article

References (41)

1. Forbes GB. Glycogen storage disease. Report of a case with abnormal glycogen structure in liver and skeletal muscle. J Pediatr 1953;42:645-50.
2. Illingworth B, Cori GT, Cori CF. Amylo-1,6-glucosidase in muscle tissue in generalized glycogen storage disease. J Biol Chem 1956;218:123.
3. Howell R. The glycogen storage diseases. In: Stanbury JB, Wyngaarden JB, Fredrickson SD, eds. The metabolic basis of inherited disease. New York: Mc Graw-Hill 1972:149-73.
4. Coleman RA, Winter HS, Wolf B, et al. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 1992;116:896-900.
5. Van Hoof F, Hers HG. The subgroups of type III glycogenosis. Eur J Biochem 1967;2:265-70.
6. Chen YT, He JK, Ding JH, et al. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease. Am J Hum Genet 1987;41:1002-15.
7. Momoi T, Sano H, Yamanaka C, et al. Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet 1992;42:696-9.
8. Hers HG, Verhue W, Van Hoof F. The determination of amylo-1,6-glucosidase. Eur J Biochem 1967;2:257-64.
9. DiMauro S, Hartwig GB, Hays A, et al. Debrancher deficiency: neuromuscular disorder in five adults. Ann Neurol 1979;5:422-36.
10. Cornelio F, Bresolin N, Singer PA, et al. Clinical varieties of neuromuscular disease in debrancher deficiency. Arch Neurol 1984;41:1027-32.
11. Brunberg JA, McCormick WF, Schochet SS. Type III glycogenosis: an adult with diffuse weakness and muscle wasting. Arch Neurol 1971;25:171-8.
12. Slonim AE, Coleman RA, Moses SW. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high protein nocturnal enterai therapy. J Pediatr 1984;105: 906-11.
13. Murase T, Ikeda H, Muro T, et al. Myopathy associated with type III glycogenosis. J Neurol Sci 1973;20:287-95.
14. Moses SW, Gadoth N, Bashan N, et al. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand 1986;75:289-96.
15. Özand P, Tokatli M, Amiri S. Biochemical investigation of an unusual case of glycogenosis. J Pediatr 1967;71:225-32.
16. Oliner L, Shulman M, Larner J. Myopathy associated with glycogen deposition resulting from generalized lack of amylo-1,6-glucosidase. Clin Res 1961;9:243.
17. Rossignol AM, Meyer M, Rossignol B, et al. La myocardiopathie de la glycogenose type III. Arch Franc Pediatr 1979; 36:303-9.
18. Bröker HJ, Kuhn E, Fiehn W, et al. Glykogenose durch Amylo-1,6-glucosidase-Mangel. Myopathie als Leitbefund im Erwachsenenalter. Schweiz Med Wochescher 1981;111: 854-8.
19. Talente GM, Coleman RA, Alter C, et al. Glycogen storage disease in adults. Ann Intern Med 1994;120:218-26.
20. Mineo I, Kono N, Hara N, et al. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V and VII. N Engl J Med 1987;317:75-80.
21. Ugawa Y, Inoue K, Takemura T, et al. Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis. Ann Neural 1986;19:294-7.
22. Marbini A, Gemignani F, Saccardi F, et al. Debrancher deficiency neuromuscular disorder with pseudohypertrophy in two brothers. J Neurol 1989;236:418-20.
23. Cohn J, Wang P. Hauge M, et al. Amylo-1,6-glucosidase deficiency (glycogenosis type III) in the Faroe Islands. Hum Hered 1975;25:115-26.
24. Pellissier JF, de Barsy TH, Faugere MC, et al. Type III glycogenosis with multicore structures. Muscle Nerve 1979;2: 124-32.
25. Yang BZ, Stewart C, Ding JH, et al. Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein. Neuromusc Dis 1991;3:173-6.
26. Powell HC, Haas R, Hall CL, et al. Peripheral nerve in type III glycogenosis: selective involvement of unmyelinated fiber Schwann cells. Muscle Nerve 1985;8:667-71.
27. Hokezu Y, Nagamatsu K, Nakagawa M, et al. An adult case of type III glycogenosis manifesting muscle hypertrophy and peripheral nerve involvement. Clin Neurol 1983;23: 473-9.
28. Rosenow EC, Engel AG. Acid maltase deficiency in adults presenting as respiratory failure. Am J Med 1978;64:485-91.
29. Chalmers RM, Howard RS, Wiles CM, et al. Respiratory insufficiency in neuronopathic and neuropathic disorders. Q J Med 1996;89:469-76.
30. Cohen R, Lipper S, Dantzker DR. Inclusion body myositis as a cause of respiratory failure. Chest 1993;104:975-7.
31. Dewberry RG, Schneider BF, Cale WF, et al. Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve 1993;16:832-5.
32. De Carvalho M, Matias T, Coelho F, et al. Motor neuron disease presenting with respiratory failure. J Neurol Sci 1996;139:117-22.
33. Shen J, Bao Y, Liu HM, et al. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996;98:352-7.
34. Paravari R, Shen J, Hershkovitz E, et al. Two new mutations in the 3′ coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient. J Inherit Metab Dis 1998;21:141-8.
35. Okubo M, Horinishi A, Nakamura N, et al. A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12 G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet 1998;102:1-5.
36. Slonim AE, Weisberg C, Benke P, et al. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 1982;11:420-2.
37. Van Hoof F. Amylo-1,6-glucosidase activity and glycogen content of the erythrocytes of normal subjects, patients with glycogen storage disease and heterozygotes. Eur J Biochem 1967;2:271-4.
38. Maire I, Baussan C, Moatti N, et al. Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem 1991;24:169-78.
39. Carvalho JS, Matthews EE, Leonard JV, et al. Cardiomyopathy of glycogen storage disease type III. Heart Vessels 1993; 8:155-9.
40. Smit GPA, Fernandes J, Leonard JV, et al. The long-term outcome of patients with glycogen storage disease. J Inherit Metab Dis 1990;13:411-8.
41. Haagsma EB, Smit GP, Niezen-Koning KE, et al. Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The liver transplant group. Hepatology 1997;25:537-40.